Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes
Open Access
- 4 March 2024
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (11)
Abstract
Treating pregnancy-related disorders is exceptionally challenging because the threat of maternal and/or fetal toxicity discourages the use of existing medications and hinders new drug development. One potential solution is the use of lipid nanoparticle (LNP) RNA therapies, given their proven efficacy, tolerability, and lack of fetal accumulation. Here, we describe LNPs for efficacious mRNA delivery to maternal organs in pregnant mice via several routes of administration. In the placenta, our lead LNP transfected trophoblasts, endothelial cells, and immune cells, with efficacy being structurally dependent on the ionizable lipid polyamine headgroup. Next, we show that LNP-induced maternal inflammatory responses affect mRNA expression in the maternal compartment and hinder neonatal development. Specifically, pro-inflammatory LNP structures and routes of administration curtailed efficacy in maternal lymphoid organs in an IL-1β-dependent manner. Further, immunogenic LNPs provoked the infiltration of adaptive immune cells into the placenta and restricted pup growth after birth. Together, our results provide mechanism-based structural guidance on the design of potent LNPs for safe use during pregnancy.Keywords
Funding Information
- HHS | NIH | Office of Extramural Research, National Institutes of Health (DP2-HD098860)
- National Science Foundation (DGE1745016)
This publication has 75 references indexed in Scilit:
- Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the PlacentaSmall, 2023
- Branching Ionizable Lipids Can Enhance the Stability, Fusogenicity, and Functional Delivery of mRNASmall Science, 2022
- Diseases and conditions that impact maternal and fetal health and the potential for nanomedicine therapiesAdvanced Drug Delivery Reviews, 2020
- Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancyAdvanced Drug Delivery Reviews, 2020
- Branched‐Tail Lipid Nanoparticles Potently Deliver mRNA In Vivo due to Enhanced Ionization at Endosomal pHSmall, 2019
- The decidua—the maternal bed embracing the embryo—maintains the pregnancySeminars in Immunopathology, 2016
- Assessment of an in vitro transport model using BeWo b30 cells to predict placental transfer of compoundsArchives of Toxicology, 2013
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013
- Role of P-glycoprotein in transplacental transfer of methadoneBiochemical Pharmacology, 2005
- Modulators of cyclic AMP metabolism induce syncytiotrophoblast formation in vitroExperimental Cell Research, 1990